Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Twist Bioscience
TWST
Twist Bioscience
Automated DNA Synthesis And AI Will Fuel Secular Growth
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
04 Aug 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$62.00
53.8% undervalued
intrinsic discount
09 Aug
US$28.65
Loading
1Y
-32.7%
7D
10.6%
Author's Valuation
US$62.0
53.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$62.0
53.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-220m
587m
2016
2018
2020
2022
2024
2025
2026
2028
Revenue US$586.9m
Earnings US$81.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
14.92%
Biotech revenue growth rate
11.40%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$81.89m
Earnings '28
x
60.83x
PE Ratio '28
=
US$4.98b
Market Cap '28
US$4.98b
Market Cap '28
/
66.02m
No. shares '28
=
US$75.46
Share Price '28
US$75.46
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$61.99
Fair Value '25